Debt to Equity Ratio Analysis of Acasti Pharma Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY Debt to Equity
Period Ending - Mar-23
Excellent Debt to Equity
0.0011
Period Ending - Mar-22
Excellent Debt to Equity
0.0010
Growth
14.90 %
Most recent Quarter Debt to Equity
Period Ending - Dec-23
Excellent Debt to Equity
0.0004
Debt to Equity Analysis of Acasti Pharma Inc
| Debt to Equity Ratio 0.0011 of Acasti Pharma Inc indicates to run a business company uses lower amount of long-term debt. |
| Debt to Equity Ratio of ACST has grown by 14.90 % Compared to previous Financial Year. |
| Debt to Equity Ratio with value of 0.130 was highest in Year Mar-19 in last Five Years. |
| Debt to Equity Ratio with value of 0.0010 was lowest in Year Mar-22 in last Five Years. |
| Latest Debt to Equity Ratio with value of 0.0011 is lower than Average Debt to Equity of 0.0279 in last five years. |
Other Debt to Equity Related Info of ACST that may interest you.
Acasti Pharma Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| ACST | 2.69 | 2.7599 | 2.53 % | Biotechnology |
Defination of Debt to Equity Ratio
Debt to Equity Ratio shows the relationship between the company's total debt and total shareholders fund. And it indicates the ability of a company's shareholders' equity to pay its debt obligations in a tough time. more ..
Debt to Equity Related Ratios
| ShortTermDebtToEquityRatio | DividendCoverageRatio | CurrentRatio |
Tsr Stability Index
| No Significant Stability | |
FY - Historical Debt to Equity Ratio of Acasti Pharma Inc
| Period | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|
| Debt to Equity | 0.0011 | 0.0010 | 0.0015 | 0.0058 | 0.130 | 0.196 | 0.065 |
| Change | 14.90 % | -37.83 % | -73.58 % | -95.51 % | -33.61 % | 202.56 % | 13013070858 % |
FY Chart of Debt to Equity Ratio of Acasti Pharma Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)